BioSpace News Archive

Avacta Group plc, a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms announces that the next pre|CISION™ drug candidate, AVA3996, has been selected for pre-clinical development with a view to a first-in-human Phase I clinical trial beginning in the second half of 2023.

Ascletis Pharma Inc. announces signing of the ritonavir tablet purchase agreement between Phokam Pharmaceutical Import-Export Co., Ltd of Laos and Ascletis Pharmaceuticals Co., Ltd., a wholly-owned subsidiary of Ascletis Pharma Inc.

DaVita Inc. announced its acquisition of transplant software company MedSleuth.

Kurin, Inc., the inventor and manufacturer of 510-cleared Kurin® blood culture sets, announced the signing of a recent agreement with AllSpire Health GPO.

ATF Medical has promoted Rick Wyche to Executive Director of Sales, Marketing and Business Development.

Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, announced the national launch of its new GeneStrat NGS™ genomic test, a blood-based tumor profiling test.

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced the publication of “Uncovering the high prevalence of bacterial burden in surgical site wounds with point-of-care fluorescence imaging"1 in International Wound Journal.

NuGen Medical Devices Inc. is pleased to announce that it has entered into an exclusive distribution agreement with Intermediq Holdings Ltd., a well-established medical distribution company in Sri Lanka.

Hyivy Health, an innovative FemTech startup developing a first-of-its-kind pelvic health rehabilitation system has raised $1.1 million in pre-seed funding.

Polyps are abnormal development of tissues projecting from a mucous membrane, normally originating in the uterus, urinary bladder, sinus, ear, nose, stomach, or colon.